Global Hemodialysis Market Size By Type (Hemodialysis (HD), Peritoneal Dialysis (PD)), By Peritoneal Dialysis Products And Services Type (Peritoneal Dialysis Machines, Peritoneal Dialysis Catheters), By Application Type (In-Center Dialysis, Hospital Dialysis), By Geographic Scope And Forecast

Hemodialysis Market Size And Forecast

Hemodialysis Market size was valued at USD 76.9 Billion in 2021 and is projected to reach USD 134.4 Billion by 2030, growing at a CAGR of 6.4% from 2023 to 2030.

As a result, it is anticipated that there would be a rise in the need for dialysis care due to the rising prevalence of ESRD globally. Annually, ESRD affects over 2 million individuals worldwide. It is projected that the demand for dialysis to maintain adequate kidney function would increase as renal disorders spread around the world. It is anticipated that there would be a major rise in the prevalence of kidney-related disorders due to the worldwide population of older people. This is thus anticipated to significantly accelerate the growth of the Hemodialysis Market throughout the projected period.

Global Hemodialysis Market Definition

Hemodialysis, which is commonly done three times a week in a clinical environment, is a procedure for filtering and purifying blood outside of the body. It entails utilizing a hemodialysis machine to remove waste and extra fluids from the patient’s blood by pumping it through a dialyzer, also known as an artificial kidney. Waste materials like urea and creatinine are eliminated from circulation by hemodialysis. By filtering the blood and preserving the proper electrolyte levels, it takes over the role of the injured or failing kidneys. The procedure assists in controlling the body’s fluid balance by eliminating extra fluid to avoid fluid retention and edema.

Hemodialysis modifies the bloodstream’s sodium, potassium, and calcium concentrations to keep them in ideal balance. By eliminating excess acid or base from the blood, the process aids in maintaining the body’s pH equilibrium. Hemodialysis can help manage blood pressure by eliminating extra fluid and controlling the body’s fluid content. Erythropoiesis-stimulating agents (ESAs) can be given during hemodialysis to promote the synthesis of red blood cells and treat anemia, which is frequently present in kidney failure patients.

Hemodialysis allows people with ESRD to eliminate waste from their blood and maintain fluid and electrolyte balance, providing them with a means of survival. Hemodialysis can reduce kidney failure symptoms including edema, weariness, and shortness of breath, which can improve a patient’s quality of life. Hemodialysis treatments are generally accessible to patients who require consistent dialysis sessions in hospitals, dialysis facilities, and home settings. Hemodialysis acts as a bridge therapy for kidney transplant candidates, keeping them stable until a suitable organ donor becomes available. Hemodialysis gives people with ESRD a better chance of long-term survival and disease control by extending their life expectancy.

The most popular kind of hemodialysis is conventional, which involves sessions that run three times a week in a clinical environment and are generally 3–4 hours long. When a patient chooses to undergo hemodialysis treatments at home, they are given the knowledge and tools necessary to carry out the process either on their own or with the help of a carer. The kind of hemodialysis known as “nocturnal hemodialysis” is carried out while the patient is asleep, enabling longer, slower treatments that can improve toxin elimination and fluid control. Short-term hemodialysis is conducted five to six times a week and comprises more frequent, shorter treatment sessions. It permits more gradual and ongoing toxin elimination, giving patients more options. In order to improve the removal of bigger waste molecules, hemodiafiltration combines hemodialysis with filtration by adding an extra filtration phase.

Global Hemodialysis Market Overview

The increased patient population in need of hemodialysis therapy is a result of the prevalence of chronic renal diseases, diabetes, hypertension, and other conditions. The hemodialysis industry is significantly fueled by the aging global population. The likelihood that an older person may need renal replacement therapy like hemodialysis increases with their susceptibility to kidney disorders. Treatment effectiveness, safety, and patient comfort have all been enhanced because to developments in hemodialysis machines, dialysis membranes, vascular access devices, and other associated technology. The availability of hemodialysis facilities has expanded, especially in developing areas, and patient knowledge of available treatments has increased as a result of the development of the healthcare infrastructure. Hemodialysis treatments are reimbursed and financially supported by public and commercial insurance programs, assuring patients’ affordability and accessibility.

Hemodialysis treatments may be quite expensive for individuals and healthcare systems, including equipment, consumables, and maintenance. The issue of affordability persists, particularly in areas with low incomes. Access to hemodialysis centers and qualified medical personnel varies, especially in rural and underdeveloped locations. Inadequate infrastructure and resources may make it difficult to provide timely and effective care. Complications with hemodialysis treatments might include infections, vascular access issues, hypotension, and anemia. Both patient satisfaction and treatment adherence may be impacted by these variables. Many people are unaware of kidney disorders and the available treatments, especially in underdeveloped nations. Delays in the start of hemodialysis can be brought on by late referrals and inadequate early identification.

Hemodialysis technology is continuing to progress, offering chances to improve patient outcomes, treatment efficiency, and convenience through wearable and portable devices, remote monitoring, and better dialysis membranes. Home-based hemodialysis treatments give patients the chance to undergo dialysis in the convenience of their own homes, encouraging independence, flexibility, and overall higher quality of life. Healthcare practitioners may remotely monitor patients’ vital signs, test findings, and treatment adherence thanks to the combination of telemedicine and remote monitoring technology, which enables prompt interventions and individualized care. As knowledge of kidney disorders and available treatments increases, developing areas with expanding healthcare infrastructure and rising disposable incomes create unexplored prospects for market development. Putting more focus on early kidney disease diagnosis, treatment, and management may assist to decrease the occurrence of ESRD.

Global Hemodialysis Market Segmentation Analysis

The Global Hemodialysis Market is Segmented on the basis of Type, Peritoneal Dialysis Products & Services Type, Application Type, and Geography.

Hemodialysis Market, By Type

• Hemodialysis (HD)
• Peritoneal dialysis (PD)
• Continuous Renal Replacement Therapy (CRRT)
• Procedure

Based on Type, the market is segmented into Hemodialysis (HD), Peritoneal dialysis (PD), Continuous Renal Replacement Therapy (CRRT), and Procedure. Hemodialysis (HD)segment holds a significant market share in 2022. Growing dialysis demand, an increase in dialysis service providers, the presence of well-established HD service providers in the market, and HD providers’ strategies for capturing sizable customer bases through the expansion of their services across the globe are all factors that contribute to this segment’s largest market share.

Hemodialysis Market, By Peritoneal Dialysis Products & Services Type

• Peritoneal Dialysis Concentrates/Dialysates
• Peritoneal Dialysis Machines
• Peritoneal Dialysis Catheters
• Peritoneal Dialysis Transfer Sets
• Peritoneal Dialysis Services
• Other products

Based on Peritoneal Dialysis Products & services Type, the market is segmented into Peritoneal Dialysis Concentrates/Dialysates, Peritoneal Dialysis Machines, Peritoneal Dialysis Catheters, Peritoneal Dialysis Transfer Sets, Peritoneal Dialysis Services and Other products. The peritoneal Dialysis Concentrates/Dialysates segment holds a significant market share in the 2022. The greatest market share in the PD concentrates/dialysates category may be ascribed to the increase in PD treatment methods as well as the increased attention given by manufacturers to improving their production skills in order to launch cutting-edge goods.

Hemodialysis Market, By Application Type

• In-Center Dialysis
• Hospital Dialysis
• Independent Dialysis
• Home Dialysis
• Peritoneal Dialysis
• Home Hemodialysis (HHD)

Based on Application Type, the market is segmented in In-Center Dialysis, Hospital Dialysis, Independent Dialysis, Home Dialysis, Peritoneal Dialysis, and Home Hemodialysis (HHD). The in-Center Dialysis segment dominated the Hemodialysis Market with the highest market share in 2022. Some of the reasons anticipated to fuel the expansion of the sector include the rising demand for dialysis products among chronic renal patients, the increased focus of players on opening independent dialysis centers, and the growing preference of patients for treatment in in-center dialysis.

Hemodialysis Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

On the basis of Geography, the Hemodialysis Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Asia Pacific region accounted for the highest market share in the Hemodialysis Market in the year 2022. Geographically, growing Asian nations like China, India, Japan, and Singapore present market participants with high-growth potential. The region’s Hemodialysis Market is projected to develop as the region’s healthcare infrastructure is expanded, disposable personal income rises, and the number of people with acute renal disease, diabetes, and hypertension increases. Additionally, government initiatives to improve the region’s access to dialysis treatment are anticipated to present substantial opportunities for businesses to attract a sizable client base.

Key Players

The “Global Hemodialysis Market” study report will provide valuable insight with an emphasis on the global market including some of the major players such as Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Cantel Medical Corp., DaVita Inc., Diaverum, Fresenius Medical Care AG & Co. KGaA, Nikkiso Co.Ltd., NxStage Medical Inc., Gambro.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players.

Key Developments

• In May 2021, Mar Cor (Cantel Medical Corporation) announced the launch of its innovative EON Portable Hemodialysis Water System.
• In August 2020, Baxter International Inc. received FDA approval for the De Novo application for Theranova dialyzers designed to deliver expanded hemodialysis (HDx) therapy.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.